Effexor and Cytarabine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Effexor (venlafaxine hydrochloride) and Cytarabine (cytarabine). Common drug interactions include cardiac failure congestive among females and acute respiratory distress syndrome among males.

The phase IV clinical study analyzes what interactions people have when they take Effexor and Cytarabine. It is created by eHealthMe based on reports of 36 people who take the same drugs from the FDA, and is updated regularly.

What is Effexor?

Effexor has active ingredients of venlafaxine hydrochloride. It is often used in depression. eHealthMe is studying from 99,493 Effexor users. Check the latest studies of Effexor.

What is Cytarabine?

Cytarabine has active ingredients of cytarabine. It is often used in acute myelogenous leukemia (aml) - adult. eHealthMe is studying from 65,358 Cytarabine users. Check the latest studies of Cytarabine.



On Jul, 09, 2026

36 people who take Effexor and Cytarabine together, and have interactions are studied.

Effexor and Cytarabine drug interactions.

What are the common drug interactions of Effexor and Cytarabine, by gender? *:

female:

  1. Cardiac failure congestive
  2. Cardiomegaly (increased size of heart than normal)
  3. Cardiomyopathy (weakening of the heart muscle)
  4. Chest discomfort
  5. Chronic myeloid leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood)
  6. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  7. Death
  8. Depressed level of consciousness
  9. Dyspnoea exertional (breathlessness or shortness of breath)
  10. Ejection fraction decreased (systolic heart failure)

male:

  1. Acute respiratory distress syndrome
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  4. Cardiogenic shock (inadequate circulation of blood)
  5. Hypotension (abnormally low blood pressure)
  6. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
  7. Multi-organ failure (multisystem organ failure)
  8. Necrotising ulcerative gingivostomatitis (life threatening infection of gums with ulcer)
  9. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  10. Vomiting

What are the common drug interactions of Effexor and Cytarabine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Depressed level of consciousness
  2. Muscular weakness (muscle weakness)

20-29:

n/a

30-39:

  1. Necrotising ulcerative gingivostomatitis (life threatening infection of gums with ulcer)
  2. Aplasia (defective development or congenital absence of an organ or tissue)
  3. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  4. Rash
  5. Paraparesis (partial paralysis of the lower limbs)
  6. Acute respiratory distress syndrome
  7. Anorexia (eating disorder characterized by immoderate food restriction and irrational fear of gaining weight)
  8. Aspergillosis (an infection caused by a fungus called aspergillus)
  9. Asthenia (weakness)
  10. Bacterial sepsis

40-49:

  1. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  2. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  4. Death
  5. Febrile neutropenia (fever with reduced white blood cells)
  6. Fluid overload (too much fluid in the blood)
  7. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  8. Opportunistic infection (a microorganism that normally does not cause disease but becomes pathogenic when the body's immune system is impaired and unable to fight)
  9. Pyrexia (fever)
  10. Sepsis (a severe blood infection that can lead to organ failure and death)

50-59:

  1. Neutropenia (an abnormally low number of neutrophils)
  2. Oxygen saturation decreased
  3. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  4. Pericardial effusion (fluid around the heart)
  5. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  6. Pyrexia (fever)
  7. Renal failure (kidney dysfunction)
  8. Respiratory disorder (respiratory disease)
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Sputum discoloured

60+:

  1. Acute respiratory distress syndrome
  2. Cardiac failure congestive
  3. Hypotension (abnormally low blood pressure)
  4. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
  5. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  6. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  7. Corynebacterium infection (infection by corynebacterium (diphtheria))
  8. Corynebacterium sepsis (sepsis which occurs when the bacterium corynebacterium jeikeium colonizes the skin of healthy individuals)
  9. Febrile bone marrow aplasia (bone marrow greatly decreases or stops production of blood cells)
  10. Haematochezia (passage of stools containing blood)

What are the existing conditions these people have? *

  1. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 11 people, 30.56%
  2. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 5 people, 13.89%
  3. High Blood Pressure: 4 people, 11.11%
  4. Stress And Anxiety: 3 people, 8.33%
  5. Aspergillosis (an infection caused by a fungus called aspergillus): 3 people, 8.33%
  6. Mouth Ulcers: 3 people, 8.33%
  7. Vitamin B12 Deficiency: 2 people, 5.56%
  8. Immunodeficiency Disorders: 2 people, 5.56%
  9. Cholestasis (a condition where bile cannot flow from the liver to the duodenum): 2 people, 5.56%
  10. Fever: 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Effexor and Cytarabine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Effexor and Cytarabine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Effexor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cytarabine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Effexor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cytarabine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on venlafaxine hydrochloride and cytarabine (the active ingredients of Effexor and Cytarabine, respectively), and Effexor and Cytarabine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: